TD Asset Management Inc decreased its stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 4.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 309,010 shares of the real estate investment trust’s stock after selling 15,474 shares during the period. TD Asset Management Inc’s holdings in Ventas were worth $23,911,000 as of its most recent filing with the SEC.
A number of other institutional investors have also made changes to their positions in the stock. GoalVest Advisory LLC acquired a new stake in Ventas in the 4th quarter worth approximately $26,000. Wiser Advisor Group LLC acquired a new position in Ventas during the third quarter valued at approximately $27,000. Elyxium Wealth LLC bought a new position in shares of Ventas in the fourth quarter valued at approximately $33,000. True Wealth Design LLC raised its position in shares of Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 138 shares during the period. Finally, AlphaQuest LLC lifted its stake in shares of Ventas by 1,848.5% in the third quarter. AlphaQuest LLC now owns 643 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 610 shares during the last quarter. 94.18% of the stock is owned by institutional investors.
Insider Activity
In other news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.53% of the company’s stock.
Ventas Price Performance
Ventas (NYSE:VTR – Get Free Report) last posted its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts expect that Ventas, Inc. will post 3.88 EPS for the current year.
Ventas Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is currently 378.18%.
Analysts Set New Price Targets
VTR has been the subject of several recent analyst reports. Jefferies Financial Group upped their price objective on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. KeyCorp raised their price target on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Mizuho set a $98.00 price objective on Ventas in a research note on Friday, May 22nd. Argus set a $88.00 price objective on Ventas in a research report on Tuesday, February 10th. Finally, Wells Fargo & Company increased their target price on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus target price of $95.19.
Read Our Latest Stock Analysis on Ventas
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Recommended Stories
- Five stocks we like better than Ventas
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
